| CAT No: | CL-BGT-006 |
| CAS No: | 1197959-30-0 |
| Mol.F: | C24H29ClN5O3P |
| Mol.Wt.: | 502 |
| Chemical Name: | (2-((5-Chloro-2-((4-(4-hydroxypiperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide |
| Inventory Status: | Custom synthesis |
This impurity is related to Brigatinib Impurity 2 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Brigatinib Impurity 2 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(2-((5-Chloro-2-((4-(4-hydroxypiperidin-1-yl)-2-methoxyphenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Brigatinib Molecular Formula: C24H29ClN5O3P
Molecular Weight: 502
Storage: Store in a cool, dry place.
| Product Name: | Brigatinib Impurity 2 |
| CAS No: | 1197959-30-0 |
| Mol.F.: | C24H29ClN5O3P |
| Mol.Wt.: | 502 |
Cat. No: CL-BGT-NO-01
CAS No: NA
Mol. F: C28H36ClN8O3P
Mol. Wt: 599.06
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-02
CAS No: NA
Mol. F: C29H38ClN8O3P
Mol. Wt: 613.09
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-03
CAS No: NA
Mol. F: C37H52ClN11O3
Mol. Wt: 734.33
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-04
CAS No: NA
Mol. F: C36H49ClN12O4
Mol. Wt: 749.31
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-05
CAS No: NA
Mol. F: C36H48ClN13O5
Mol. Wt: 778.3
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-06
CAS No: NA
Mol. F: C36H47ClN14O6
Mol. Wt: 807.3
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-07
CAS No: NA
Mol. F: C24H27ClN7O5P
Mol. Wt: 559.94
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-08
CAS No: NA
Mol. F: C24H28ClN6O4P
Mol. Wt: 530.94
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-09
CAS No: NA
Mol. F: C29H38ClN8O3P
Mol. Wt: 613.09
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-10
CAS No: NA
Mol. F: C29H37ClN9O4P
Mol. Wt: 642.09
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-11
CAS No: NA
Mol. F: C29H36ClN10O5P
Mol. Wt: 671.09
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-12
CAS No: NA
Mol. F: C30H40ClN8O3P
Mol. Wt: 627.12
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-13
CAS No: NA
Mol. F: C30H39ClN9O4P
Mol. Wt: 656.12
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-14
CAS No: NA
Mol. F: C20H25Cl2N7O2
Mol. Wt: 466.36
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-15
CAS No: NA
Mol. F: C20H24Cl2N8O3
Mol. Wt: 495.36
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-16
CAS No: NA
Mol. F: C28H34ClN10O5P
Mol. Wt: 657.06
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-17
CAS No: NA
Mol. F: C28H35ClN9O4P
Mol. Wt: 628.06
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-NO-18
CAS No: NA
Mol. F: C28H36ClN8O3P
Mol. Wt: 599.06
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-001
CAS No: 1197953-54-0
Mol. F: C29H39ClN7O2P
Mol. Wt: 584.1
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-002
CAS No: 1197961-02-6
Mol. F: C30H41ClN7O2P
Mol. Wt: 598.1
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-003
CAS No: 1197958-75-0
Mol. F: C28H37ClN7O2P
Mol. Wt: 570.1
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-004
CAS No: 1197960-18-1
Mol. F: C30H41ClN7O2P
Mol. Wt: 598.1
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-005
CAS No: NA
Mol. F: C38H55ClN10O2
Mol. Wt: 719.4
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-007
CAS No: 1259274-28-6
Mol. F: C21H28Cl2N6O
Mol. Wt: 451.4
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-008
CAS No: 2055306-71-1
Mol. F: C29H36D3ClN7O2P
Mol. Wt: 587.1
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-009
CAS No: 2055306-74-4
Mol. F: C29H31D8ClN7O2P
Mol. Wt: 592.2
Inv. Status: Custom Synthesis
Cat. No: CL-BGT-010
CAS No: 2055306-76-6
Mol. F: C29H28D11ClN7O2P
Mol. Wt: 595.2
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: